Registry on H. pylori Infection Management in Argentina
Part of Digestive system, Infections clinical trials.
This registry study tracks how H. pylori infection is managed in Argentina. It aims to collect real-world data to improve treatment for this common stomach infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older) with a confirmed Helicobacter pylori infection.
- You are not pregnant or breastfeeding.
- You are not currently taking any antibiotics.
- You have not taken any antibiotics or bismuth-containing medicines in the last 4 weeks.
- You have not taken a proton pump inhibitor (acid-reducing medicine like omeprazole) in the last 2 weeks.
- You are able and willing to give your consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that follows adults who have Helicobacter pylori (a common stomach bacteria) to learn how it’s managed in real life. It may help improve care by tracking treatments and outcomes over time.
This study is creating a registry of people with Helicobacter pylori (H. pylori) infection in Shandong Province who choose to have treatment. It will gather information to improve how H. pylori infections are managed.
This study is testing whether giving H. pylori treatment based on the specific bacteria found in your stomach works better than the standard one-size-fits-all approach. If you are already getting an endoscopy with a biopsy, this trial could help find the most effective medication for your infection.
This study looks at how common a stomach bacteria infection is and which antibiotics still work. You may help researchers by providing consent for related study participation and sample tracking.
This study follows adults with past or current H. pylori infection to better understand stomach lining changes such as atrophic gastritis and intestinal metaplasia, and to monitor for possible progression. It may help by improving how doctors track risk over time and use stored tissue samples to learn more.
This study compares two ways to treat Helicobacter pylori (H. pylori) infection that didn’t go away with prior therapy. One approach uses test results to guide which medicines to use, and the other uses standard (“empiric”) treatment. The goal is to see which works better and more safely as a rescue plan.
Hear when a new H. Pylori Gastrointestinal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.